Insider · CIK 0001638727
John Martin Docherty
Files at LEXX (Lexaria Bioscience Corp.). First filing Jul 30, 2025, latest Jul 30, 2025.
In brief
John Martin Docherty files SEC Form 4 as president and director at LEXX (Lexaria Bioscience Corp.). Since Jul 30, 2025, John Martin Docherty has reported 1 open-market buy worth $4,989 and 0 open-market sells worth $0, the latest filed on Jul 30, 2025.
A track record needs three past buys with six months of prices behind them; John Martin Docherty has 0, so none is measured yet.
The newest scored trade: bought $4,989 of LEXX on Jul 29, 2025, filed Jul 30, 2025, scored 61 (notable).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
LEXX: Lexaria Bioscience Corp.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 61Notable | Lexaria Bioscience Corp. | $4,989 5,376 shares | - | +9% from low-75% from high |
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 29, 2025 | LEXX Lexaria Bioscience Corp. | POpen-market purchase common shares | +5,376 | $0.93 | $4,989 | 5,376 | Jul 30, 2025 |
| May 15, 2025 | LEXX Lexaria Bioscience Corp. | AGrant or award Stock Optionsderivative | +150,000 | $0.00 | $0 | 310,834 | May 16, 2025 |
| Apr 26, 2024 | LEXX Lexaria Bioscience Corp. | AGrant or award Stock Optionsderivative | +49,500 | $0.00 | $0 | 174,168 | May 10, 2024 |
| Oct 26, 2023 | LEXX Lexaria Bioscience Corp. | AGrant or award Stock Optionsderivative | +30,000 | $0.00 | $0 | 124,668 | Oct 30, 2023 |
Questions about John Martin Docherty
Answered from the filings on this page, as of the latest one.
Is John Martin Docherty buying or selling?
Not in the last 12 months. John Martin Docherty's latest open-market trade on SEC Form 4 was bought $4,989 of LEXX on Jul 29, 2025.
How did John Martin Docherty's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and John Martin Docherty has 0.
Where does John Martin Docherty file Form 4?
John Martin Docherty has filed Form 4 at LEXX (Lexaria Bioscience Corp.) as President. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.